Clinical overview
Febrile Seizures requires a structured clinical assessment that identifies immediate risk, confirms the working diagnosis where possible and links treatment to current paediatrics guidance. Interpret symptoms, examination findings, investigations, medicines and trajectory together rather than relying on one threshold.
Initial assessment
Use age-specific observations, weight, developmental stage, safeguarding context and caregiver history. Recognise that infants and children can compensate before sudden deterioration.
Diagnostic strategy
Use history, examination and targeted tests to confirm the syndrome and exclude important alternatives. Interpret results with timing, pre-test probability, treatment exposure and test limitations. Repeat or escalate investigation when the clinical course is discordant.
Management principles
Use paediatric doses, fluids, equipment and escalation pathways and involve parents or carers in safety-netting.
Monitoring and follow-up
Define treatment goals, expected response, adverse-effect monitoring and review interval. Document who is responsible for follow-up and the findings that should trigger earlier reassessment.
Special populations
Pregnancy, childhood, older age, frailty, kidney or liver dysfunction, disability and immunosuppression may require different thresholds, medicines or escalation. Use population-specific guidance.
Clinical pearls
- Trend and functional change often matter more than one result.
- Confirm that a calculator or rule applies to this population.
- Make the safety-net and escalation plan explicit.
Common mistakes
- Relying on one normal test despite persistent clinical concern.
- Failing to review medicines and treatment-related harm.
- Using a score as a substitute for clinical judgement.
- Leaving responsibility for follow-up unclear.
Escalation triggers
Escalate urgently for apnoea, cyanosis, severe respiratory distress, shock, altered consciousness, non-blanching rash, safeguarding concern or rapid deterioration, or whenever the required monitoring, diagnostic access or treatment capability is unavailable.
Related MediCalc clinical tools
Related Clinical References
Frequently asked questions
Can this reference replace a local pathway?
No. Use current local and national guidance, prescribing policy and specialist escalation procedures.
When should the diagnosis be reconsidered?
Reconsider it when symptoms progress, objective findings remain unexplained or the expected treatment response does not occur.
Key practice points
- Recognise immediate risk.
- Confirm the syndrome where possible.
- Use treatment safely.
- Review response and function.
- Provide clear safety-netting and follow-up.